Whole-genome screen identifies diverse pathways that negatively regulate ciliogenesis.


Journal

Molecular biology of the cell
ISSN: 1939-4586
Titre abrégé: Mol Biol Cell
Pays: United States
ID NLM: 9201390

Informations de publication

Date de publication:
15 01 2021
Historique:
pubmed: 19 11 2020
medline: 13 8 2021
entrez: 18 11 2020
Statut: ppublish

Résumé

We performed a high-throughput whole-genome RNAi screen to identify novel inhibitors of ciliogenesis in normal and basal breast cancer cells. Our screen uncovered a previously undisclosed, extensive network of genes linking integrin signaling and cellular adhesion to the extracellular matrix (ECM) with inhibition of ciliation in both normal and cancer cells. Surprisingly, a cohort of genes encoding ECM proteins was also identified. We characterized several ciliation inhibitory genes and showed that their silencing was accompanied by altered cytoskeletal organization and induction of ciliation, which restricts cell growth and migration in normal and breast cancer cells. Conversely, supplying an integrin ligand, vitronectin, to the ECM rescued the enhanced ciliation observed on silencing this gene. Aberrant ciliation could also be suppressed through hyperactivation of the YAP/TAZ pathway, indicating a potential mechanistic basis for our findings. Our findings suggest an unanticipated reciprocal relationship between ciliation and cellular adhesion to the ECM and provide a resource that could vastly expand our understanding of controls involving "outside-in" and "inside-out" signaling that restrain cilium assembly.

Identifiants

pubmed: 33206585
doi: 10.1091/mbc.E20-02-0111
pmc: PMC8120696
doi:

Substances chimiques

Actins 0
Integrins 0
Ligands 0
RNA, Small Interfering 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

169-185

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM120776
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA207659
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA220518
Pays : United States

Références

Nature. 2010 Apr 15;464(7291):1048-51
pubmed: 20393563
Nat Cell Biol. 2008 Sep;10(9):1062-8
pubmed: 19160486
Nat Commun. 2018 Apr 30;9(1):1732
pubmed: 29712905
J Cell Sci. 2017 Nov 1;130(21):3698-3712
pubmed: 28883094
Nat Commun. 2018 Aug 17;9(1):3310
pubmed: 30120249
J Clin Invest. 2019 May 16;129(7):2841-2855
pubmed: 31094706
Genes Dev. 2007 Nov 1;21(21):2747-61
pubmed: 17974916
Immunol Rev. 2007 Aug;218:45-64
pubmed: 17624943
J Cell Biol. 2006 May 8;173(3):383-94
pubmed: 16651381
J Biol Chem. 2001 Jul 27;276(30):28164-70
pubmed: 11382782
Cancer Res. 2017 Sep 15;77(18):5129-5141
pubmed: 28687620
Curr Biol. 2010 Apr 27;20(8):731-7
pubmed: 20381354
Front Biosci (Landmark Ed). 2015 Jun 01;20:1144-63
pubmed: 25961550
Oncotarget. 2016 Mar 1;7(9):9975-92
pubmed: 26862738
Oncogene. 2017 Jun 8;36(23):3252-3262
pubmed: 28092671
J Biol Chem. 2002 Jun 14;277(24):22073-84
pubmed: 11934885
J Cell Sci. 2009 Aug 1;122(Pt 15):2716-26
pubmed: 19596800
Cancer Res. 2011 Jun 1;71(11):4002-14
pubmed: 21632555
Front Cell Neurosci. 2019 Feb 20;13:55
pubmed: 30842728
Microsc Res Tech. 2000 Nov 1;51(3):280-301
pubmed: 11054877
Sci Rep. 2019 Feb 4;9(1):1116
pubmed: 30718762
J Biosci Bioeng. 2018 Jan;125(1):8-14
pubmed: 28811097
J Cell Biol. 2016 Feb 15;212(4):409-23
pubmed: 26880200
Curr Opin Cell Biol. 2012 Oct;24(5):652-61
pubmed: 22819513
Oncogene. 2000 Jun 15;19(26):3013-20
pubmed: 10871853
Cell Motil Cytoskeleton. 2006 Jun;63(6):341-55
pubmed: 16550544
Int J Biochem Cell Biol. 1999 May;31(5):539-44
pubmed: 10399314
Nat Commun. 2015 Apr 07;6:6781
pubmed: 25849865
Cell Cycle. 2013 Mar 1;12(5):849-58
pubmed: 23388454
EMBO Rep. 2016 May;17(5):708-23
pubmed: 27113750
Biochim Biophys Acta. 2008 Dec;1786(2):114-25
pubmed: 18343234
Nat Commun. 2017 May 15;8:15321
pubmed: 28504269
Am J Physiol Renal Physiol. 2004 Nov;287(5):F969-78
pubmed: 15226154
J Biol Chem. 2006 Jul 7;281(27):18652-9
pubmed: 16698790
Blood. 2017 Feb 23;129(8):950-958
pubmed: 27899358
J Histochem Cytochem. 2006 Sep;54(9):1005-14
pubmed: 16651393
J Cell Sci. 2007 Oct 15;120(Pt 20):3491-9
pubmed: 17928305
J Histochem Cytochem. 2010 Oct;58(10):857-70
pubmed: 20530462
Exp Cell Res. 2007 Oct 1;313(16):3616-23
pubmed: 17673200
Cilia. 2014 Jul 01;3:7
pubmed: 24987519
Cancer Biol Ther. 2004 Jan;3(1):36-41
pubmed: 14739782
Nat Commun. 2019 Feb 27;10(1):953
pubmed: 30814516
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20555-9
pubmed: 23185005
Nature. 2000 Dec 7;408(6813):732-5
pubmed: 11130076
Proc Natl Acad Sci U S A. 2017 Aug 29;114(35):9349-9354
pubmed: 28739949
J Cell Biol. 2017 Nov 6;216(11):3713-3728
pubmed: 28993469
Br J Cancer. 2013 Nov 26;109(11):2810-8
pubmed: 24169345
Nat Rev Genet. 2010 May;11(5):331-44
pubmed: 20395968
Nat Cell Biol. 2016 Jun 28;18(7):711-7
pubmed: 27350441
Nat Cell Biol. 2015 Aug;17(8):1074-1087
pubmed: 26167768
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
pubmed: 11553815
Cell. 2015 Dec 3;163(6):1484-99
pubmed: 26638075
J Cell Biol. 2004 May 24;165(4):539-51
pubmed: 15159419
Genes Dev. 2013 Jan 15;27(2):163-8
pubmed: 23348840
Cell Signal. 1996 Jun;8(4):235-45
pubmed: 8842523
J Endocrinol. 2011 May;209(2):139-51
pubmed: 21307119
J Biomol Screen. 2011 Aug;16(7):775-85
pubmed: 21515799
Development. 2018 Sep 17;145(18):
pubmed: 30224385
Sci Transl Med. 2019 May 22;11(493):
pubmed: 31118289
Methods Enzymol. 2013;525:45-58
pubmed: 23522464
Nat Commun. 2015 Aug 20;6:8087
pubmed: 26290419
Nat Methods. 2009 Aug;6(8):569-75
pubmed: 19644458
J Cell Biol. 2001 Jul 9;154(1):177-86
pubmed: 11448999
J Clin Invest. 2011 Jul;121(7):2750-67
pubmed: 21633166
Dev Biol. 2012 Dec 1;372(1):28-44
pubmed: 23000969

Auteurs

Marion Failler (M)

Department of Pathology and Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016.

Ariadna Giro-Perafita (A)

Department of Pathology and Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016.

Mikito Owa (M)

Department of Pathology and Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016.

Shalini Srivastava (S)

Department of Pathology and Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016.

Chi Yun (C)

Department of Pathology and Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016.

David J Kahler (DJ)

Department of Pathology and Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016.

Derya Unutmaz (D)

Jackson Laboratory for Genomic Medicine and University of Connecticut School of Medicine, Farmington, CT 06031.

Francisco J Esteva (FJ)

Department of Pathology and Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016.

Irma Sánchez (I)

Department of Pathology and Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016.

Brian D Dynlacht (BD)

Department of Pathology and Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH